Broadcom IncSamsung signed a $200B+ deal for memory and foundry chips through 2030, including HBM for Broadcom's AI accelerators.
Stock index futures edged higher on Monday as a pause in U.S.-Iran military strikes eased fears of a broader Middle East conflict. Forte Biosciences shares jumped 39% after argenx SE agreed to acquire the company for $77 per share in cash, valuing the deal at about $2.2 billion and representing an 86% premium to Forte’s volume-weighted average price since reporting positive Phase 1b vitiligo data on July 9. Broadcom rose 2.5% after Samsung Electronics signed a memorandum of understanding to supply memory and foundry chips through 2030 in a deal valued at over $200 billion, with the memory component focusing on HBM for Broadcom’s next-generation AI accelerators and the foundry part centered on Samsung’s 2-nanometer and below process technologies. General Motors gained 2% as Jefferies upgraded the stock to buy from hold with a $99 price target, citing confidence that 2027 will strengthen the automaker’s position within the U.S. profit oligopoly. Exxon Mobil fell 3% alongside the broader oil and gas sector as crude prices tumbled more than 5% on hopes for a diplomatic solution to de-escalate the conflict and allow shipping to resume through the Strait of Hormuz. Everbright Digital declined 5% after pricing a public offering of 4.29 million ordinary shares at $1.88 per share for total gross proceeds of around $8.07 million, with net proceeds intended for general corporate purposes and working capital needs.
Broadcom IncSamsung signed a $200B+ deal for memory and foundry chips through 2030, including HBM for Broadcom's AI accelerators.
Samsung Electronics Co LtdSamsung signed a $200B+ deal to supply memory and foundry chips to Broadcom through 2030.
Forte Biosciences Incargenx agreed to acquire Forte for $77/share, an 86% premium.
General Motors CompanyJefferies upgraded GM to buy with $99 target, citing confidence in 2027 position.
Exxon Mobil CorpCrude prices tumbled >5% on hopes for diplomatic solution to de-escalate conflict, easing supply disruption fears.
argenx NV ADRargenx agreed to acquire Forte Biosciences for $77/share, a strategic acquisition.
Jefferies Financial Group Inc